Get Your Personalized Supplement StackSupplement Stack Quiz

Bonduc

Also known as: Bonduc, Fever nut, Gray Nicker, Bonducella bonducella, Caesalpinia bonduc

Overview

Caesalpinia bonduc, commonly known as Bonduc, is a tropical leguminous plant whose seeds and other parts have been traditionally utilized in folk medicine for various ailments. The supplement ingredient typically refers to extracts derived from the seeds of this plant. It is categorized as an herbal supplement and traditional medicinal plant extract. Primary uses in traditional medicine include antifungal, anti-inflammatory, antipyretic, and potentially immunomodulatory applications. The plant is characterized by the presence of bioactive phytochemicals such as flavonoids, saponins, and alkaloids, which are believed to contribute to its therapeutic effects. Research on Bonduc is still emerging, with most studies being in vitro or in vivo, focusing primarily on its antimicrobial and antifungal properties. However, the overall quality of evidence is limited, with a notable absence of high-quality randomized controlled trials (RCTs) or systematic reviews in human subjects.

Benefits

The most compelling evidence for Bonduc's benefits is its **anticandidal (antifungal) activity**, particularly against *Candida albicans*, a common pathogenic yeast. One in vitro study demonstrated that an ethanolic extract of *C. bonduc* seeds (EECS) significantly inhibited *C. albicans* growth and explored its mechanisms of action, suggesting its potential for managing multidrug-resistant fungal infections. This research, while promising, is preclinical and does not involve human subjects. There are currently no high-quality randomized controlled trials (RCTs) or meta-analyses on human clinical outcomes of Bonduc supplementation available. Therefore, while the in vitro data is encouraging for its antifungal properties, clinical efficacy in humans remains unproven. Other traditional benefits, such as anti-inflammatory or analgesic effects, are largely anecdotal or based on preclinical data, lacking robust scientific validation in human studies.

How it works

The primary mechanism of action for Bonduc's observed antifungal effects appears to involve the disruption of fungal cell membranes and the inhibition of biofilm formation, particularly in *Candida* species. The bioactive phytochemicals present in Bonduc seeds, such as flavonoids, saponins, and alkaloids, are thought to induce oxidative stress within fungal cells, ultimately leading to cell death. These compounds likely interact with essential fungal enzymes and cellular pathways critical for their survival and proliferation. However, the specific molecular targets and comprehensive pathways are still under investigation. Information regarding the absorption, distribution, metabolism, and excretion (ADME) of Bonduc's active compounds, as well as their bioavailability in humans, is not well characterized.

Side effects

Comprehensive safety data and adverse event profiles from clinical trials for Bonduc are currently unavailable. While traditional use suggests general tolerability, formal toxicology studies in humans are lacking. Due to the absence of robust clinical data, the potential for allergic reactions or interactions with conventional medications, particularly antifungal drugs, cannot be definitively excluded. There are no documented contraindications or specific drug interactions reported from high-quality scientific sources. Users should exercise caution, especially if they have known allergies to plants in the Fabaceae family or are taking other medications. Without sufficient safety studies, the full spectrum of potential side effects, their severity, and frequency remain unknown. Pregnant or breastfeeding individuals, and those with pre-existing medical conditions, should avoid use due to the lack of safety information.

Dosage

There are no established dosing guidelines for Bonduc derived from clinical trials or systematic reviews in humans. Current experimental studies primarily utilize ethanolic extracts at concentrations relevant to in vitro assays, which are not directly translatable to human oral dosages. Without comprehensive human pharmacokinetic and safety data, reliable dosing recommendations cannot be made. The form and absorption factors for human consumption are also not well characterized. There are no specified upper limits or safety thresholds for Bonduc supplementation. Any current use is largely based on traditional practices or experimental contexts, and individuals should be aware that there is no scientific consensus on a safe or effective dose for any specific health condition.

FAQs

Is Bonduc effective against fungal infections?

Preclinical evidence supports antifungal activity against *Candida albicans* in laboratory settings. However, clinical efficacy in humans remains unproven, as there are no human trials to confirm these effects.

Is it safe to use Bonduc supplements?

Safety data for Bonduc in humans are insufficient. Caution is strongly advised until more comprehensive studies are available to establish its safety profile and potential side effects.

How should Bonduc be taken?

There is no standardized dosing or formulation established for Bonduc. Current use is primarily experimental or based on traditional practices, with no scientifically validated guidelines for human consumption.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC9449877/ – This in vitro study investigated the antifungal activity of ethanolic extract of *Caesalpinia bonduc* seeds (EECS) against various *Candida* species, including *Candida albicans*. The research demonstrated significant antifungal activity, showing that EECS could inhibit fungal growth and disrupt fungal cell membranes. The study provides promising preclinical evidence for Bonduc's potential as an antifungal agent, but it lacks human data and is limited to laboratory assays.